A Multidisciplinary Approach to Improve the Management of Immune-Checkpoint Inhibitor-Related Pneumonitis.
Monica ValenteMaura ColucciVirginia VegniValentina CroceCristiana BellanGiulia RossiGiulia GibiliscoFrancesco FrongiaRaffaella GuazzoClaudia GhiribelliElena BargagliVinno SavelliMatteo RavaraTommaso SaniElena SimonettiMichele MaioLuana CalabròAnna Maria Di GiacomoPublished in: OncoTargets and therapy (2024)
Im-PN is a rare but challenging side effect of ICI therapy, with variable time of onset and with heterogeneous clinical and radiological presentations. A multidisciplinary assessment is mandatory to optimize the clinical management of im-PN.